COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 177 filers reported holding COHERUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,931 | -99.2% | 1,155 | -98.7% | 0.00% | -100.0% |
Q1 2023 | $600,893 | -16.2% | 87,850 | -2.9% | 0.00% | 0.0% |
Q4 2022 | $716,711 | -9.2% | 90,494 | +9.9% | 0.00% | -50.0% |
Q3 2022 | $789,000 | +1.0% | 82,353 | -23.8% | 0.00% | 0.0% |
Q2 2022 | $781,000 | +181.9% | 108,042 | +402.5% | 0.00% | – |
Q1 2022 | $277,000 | -71.5% | 21,500 | -67.7% | 0.00% | -100.0% |
Q1 2021 | $971,000 | -38.5% | 66,535 | -26.8% | 0.00% | -33.3% |
Q4 2020 | $1,578,000 | +31.2% | 90,851 | +38.3% | 0.00% | 0.0% |
Q3 2020 | $1,203,000 | +31.5% | 65,682 | +28.1% | 0.00% | +50.0% |
Q2 2020 | $915,000 | -8.7% | 51,289 | -16.9% | 0.00% | -33.3% |
Q1 2020 | $1,002,000 | +51.4% | 61,756 | +67.8% | 0.00% | +200.0% |
Q4 2019 | $662,000 | -67.3% | 36,800 | -63.2% | 0.00% | -75.0% |
Q3 2019 | $2,026,000 | +2311.9% | 100,004 | +1598.4% | 0.00% | – |
Q2 2017 | $84,000 | -84.6% | 5,888 | -77.1% | 0.00% | -100.0% |
Q1 2017 | $545,000 | -48.0% | 25,727 | -30.7% | 0.00% | -50.0% |
Q4 2016 | $1,048,000 | – | 37,117 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |